CIBC Bancorp USA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
CIBC Bancorp USA's AMGN Position: Q2 2026 in Review
CIBC Bancorp USA reduced its Amgen (AMGN) stake by 2.9% in Q2 2026, selling an estimated $5.42M and leaving 529,613 shares worth $192M. The position accounts for 0.23% of the portfolio, ranked #102.
CIBC Bancorp USA first reported a position in AMGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $192M in Q1 2026. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- CIBC Bancorp USA held 529,613 shares of Amgen worth $192M as of Q2 2026.
- CIBC Bancorp USA sold 15,848 Amgen shares in Q2 2026, an estimated $5.42M.
- Amgen made up 0.23% of CIBC Bancorp USA's portfolio in Q2 2026, its #102 holding.
- CIBC Bancorp USA first reported a position in Amgen in Q3 2025 and has held it in 3 quarters since.
- CIBC Bancorp USA's Amgen position peaked at $192M in Q1 2026.
- 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.